XBiotech (XBIT) Return on Equity [ROE] (2015 - 2026)
XBiotech's Return on Equity [ROE] was -30.79% in Q2 2026, down 14.59 percentage points from -16.20% a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at XBiotech came in at -28.23%, down 9.02 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -26.20 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -19.21% in FY2024 (-8.52 pp), -10.69% in FY2023 (+2.21 pp), -12.91% in FY2022 (-7.27 pp) and -5.64% in FY2021 (-3.60 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] since Q3 2019.
- Compared with a year earlier, Return on Equity [ROE] was higher in 1 of the last seven quarters, with an average year-over-year change of -6.66 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2023 (a gain of 4.18 percentage points); the worst was Q3 2021 (a drop of 200.45 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.97% |
| 10 | XBiotech | 67.07 Mn | 67.07 Mn | - | -30.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30.79% |
| Dec 31, 2025 | -29.63% |
| Sep 30, 2025 | -17.14% |
| Jun 30, 2025 | -16.20% |
| Mar 31, 2025 | -22.08% |
| Dec 31, 2024 | -20.58% |
| Sep 30, 2024 | -16.80% |
| Jun 30, 2024 | -17.25% |
| Mar 31, 2024 | -14.36% |
| Dec 31, 2023 | -11.16% |
| Sep 30, 2023 | -10.27% |
| Jun 30, 2023 | -12.23% |
| Mar 31, 2023 | -13.16% |
| Dec 31, 2022 | -13.56% |
| Sep 30, 2022 | -14.45% |
| Jun 30, 2022 | -10.27% |
| Mar 31, 2022 | -7.57% |
| Dec 31, 2021 | -6.41% |
| Sep 30, 2021 | -4.11% |
| Jun 30, 2021 | -3.44% |
API Access
XBiotech Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();